FDA approves Galderma’s Epiduo Forte Gel

FORT WORTH, Texas — Galderma Laboratories announced Thursday that the Food and Drug Administration had approved it Epiduo Forte Gel, an antibiotic-free daily treatment for acne vulgaris.

“As the industry leader in dermatology, Galderma recognizes the need for innovative acne medications across a spectrum of acne severities,” Galderma President and General Manager Todd Zavodnick said. “The FDA approval of Epiduo Forte Gel has helped us expand on our robust acne franchise to deliver a safe, effective and antibiotic-free treatment to patients in need, and underscores Galderma’s continued commitment to skin health and antibiotic stewardship.”

Epiduo Forte Gel has the highest concentration of adapalene, a chemical that unblocks pores and helps prevent acne from forming under the skin, which also reduces the redness and inflammation that comes along with acne. It will be available for prescription in early September.